14-3-3 zeta as novel molecular target for cancer therapy
- 18 April 2012
- journal article
- review article
- Published by Informa UK Limited in Emerging Therapeutic Targets
- Vol. 16 (5), 515-523
- https://doi.org/10.1517/14728222.2012.668185
Abstract
14-3-3ζ acts as a central hub in signaling networks, which promotes cell proliferation, adhesion and survival and inhibits apoptosis in multiple cancers. Development of inhibitors or agents that interfere with 14-3-3ζ-dependent signaling networks are likely to serve as novel molecular agents for targeted cancer therapy. The role of 14-3-3ζ in cancer and its potential as a novel molecular target for therapy. The involvement of 14-3-3ζ in chemoresistance in multiple cancers provides a rationale for developing novel molecular therapies targeting this protein for more effective cancer management. The keywords used to conduct the literature search for this paper were '14-3-3/14-3-3zeta and cancer', '14-3-3 structure', '14-3-3 inhibitors', '14-3-3 cancer prognosis', '14-3-3 and cancer therapy', 'role/ functions of 14-3-3'. 14-3-3ζ is a central cellular hub protein regulating multiple signaling pathways involved in cancer development, progression and therapeutic resistance. Thus, 14-3-3ζ may serve as a novel molecular target for cancer therapy. New approaches including synthetic and/or natural inhibitors that interfere with 14-3-3ζ-client interactions need to be developed for effective cancer therapy.Keywords
This publication has 80 references indexed in Scilit:
- 14-3-3 proteins as signaling integration points for cell cycle control and apoptosisSeminars in Cell & Developmental Biology, 2011
- Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunitOncogene, 2011
- Regulation of autophagic activity by 14-3-3ζ proteins associated with class III phosphatidylinositol-3-kinaseCell Death & Differentiation, 2010
- Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancerNature Medicine, 2010
- 14-3-3ζ Cooperates with ErbB2 to Promote Ductal Carcinoma In Situ Progression to Invasive Breast Cancer by Inducing Epithelial-Mesenchymal TransitionCancer Cell, 2009
- Copy number gain and oncogenic activity of YWHAZ/14‐3‐3ζ in head and neck squamous cell carcinomaInternational Journal of Cancer, 2009
- The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer developmentTrends in Cell Biology, 2008
- The TSC1–TSC2 complex: a molecular switchboard controlling cell growthBiochemical Journal, 2008
- Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070Leukemia, 2007
- Structural basis for protein–protein interactions in the 14-3-3 protein familyProceedings of the National Academy of Sciences of the United States of America, 2006